Insulet | PODD - Creditori Commerciali

Prezzo Delle Azioni
199.33
Cambio Giornaliero
-4.18 -2.05%
Mensile
-16.33%
Annuale
-20.73%
Q2 Previsione
198.16




Creditori Commerciali Cambiamento Data
Abbott USD 4.12B 183M 2025-09
Align Technology USD 121.45M 4.1M 2025-12
AtriCure USD 78.4M 3.56M 2025-12
Avanos Medical USD 55.5M 1.3M 2025-12
Baxter International USD 999M 46M 2025-12
Becton, Dickinson and Co. USD 6.14B 4.16B 2025-12
Boston Scientific USD 1.14B 142M 2025-12
Cardinal Health USD 39B 2.14B 2025-12
Cooper Companies USD 225.8M 74.6M 2025-12
Dexcom USD 1.83B 1.38B 2025-12
Edwards Lifesciences USD 165M 94.2M 2025-09
Eli Lilly USD 5.38B 1.12B 2025-12
Globus Medical USD 98.85M 11.62M 2025-12
ICU Medical USD 154.37M 17.38M 2025-12
Inogen USD 21.22M 684K 2025-09
Insulet USD 75M 26.8M 2025-12
Integra LifeSciences USD 95.73M 3.42M 2025-12
J&J USD 11.99B 2.37B 2025-12
Masimo USD 103M 14.9M 2025-12
Medtronic USD 2.57B 12M 2025-12
Merit Medical Systems USD 60.55M 4.19M 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Solventum Corp USD 687M 18M 2025-12
Stryker USD 1.5B 56M 2025-09
Tandem Diabetes Care USD 47.07M 414K 2025-12
Teleflex USD 130.2M 35.71M 2025-12
West Pharmaceutical Services USD 253.7M 2.1M 2025-12
Zimmer Biomet Holdings USD 303M 12.3M 2025-12